The Return of the Biotech IPO
It isn’t just the volume of IPOs this summer that makes this window a victory for hibernating private biotechs and their VC backers, it’s the details of the offerings in terms of price, performance,...
View ArticleBIO Investor Forum Interview with Regado Biosciences
BIO is very excited to be hosting the BIO Investor Forum next week in San Francisco. The BIO One-on-One Partnering System has already scheduled over 640 meetings, which is a 50% increase over last...
View Article
More Pages to Explore .....